Evidence map›Paper›PMID 40143690›Full record

ArticleCurrent medicinal chemistry2026

Identification of a Protein-truncating Variant in

Monis Bilal Shamsi, Muhammad Zeeshan Ali, Safeer Ahmad, Mari Muurinen, Muzammil Ahmad Khan, Mohammed Turki Hussain Alharthi, Muhammad Latif

Abstract read
In one paragraph

Article in Current medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Monis Bilal ShamsiCentre for Genetics and Inherited Diseases (CGID), Taibah University, Madinah, 42353, Saudi Arabiarabia.ORCID 0000-0003-2158-6349
Muhammad Zeeshan AliGomal Center of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan, Pakistan.ORCID 0009-0001-9936-4431
Safeer AhmadGomal Center of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan, Pakistan.ORCID 0000-0002-1149-5665
Mari MuurinenResearch Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.ORCID 0009-0008-5595-4334
Muzammil Ahmad KhanGomal Center of Biochemistry and Biotechnology, Gomal University, Dera Ismail Khan, Pakistan.
Mohammed Turki Hussain AlharthiDepartment Basic Medical Sciences, College of Medicine, Taibah University, Madinah, 42353, Saudi Arabia.ORCID 0000-0002-1730-2086
Muhammad LatifCentre for Genetics and Inherited Diseases (CGID), Taibah University, Madinah, 42353, Saudi Arabia.ORCID 0000-0003-4858-3324

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntellectual disability (ID) is characterized by impairments in cognitive functioning and adaptive behavior. Globally, it affects 1-3% of the general population, with an increased prevalence in consanguineous families. It is a clinically heterogeneous disorder that can manifest as a variable phenotype. Intellectual developmental disorder and retinitis pigmentosa (IDDRP) is a rare syndrome in which patients present with both ID and retinitis pigmentosa. AIMS AND

objectivesThis study examined a consanguineous family to identify disease-associated pathogenic mutations and elucidate their potential functional impact in patients with IDDRP. METHODOLOGY: Clinical assessment of the patients revealed characteristics consistent with both intellectual disability (ID) and retinitis pigmentosa. Individuals affected by IDDRP were subjected to whole exome sequencing (WES), and the identified candidate pathogenic variants were validated by Sanger sequencing. Computational analyses were conducted to evaluate the impact of these mutations on the protein structure and function.

resultsWES identified a protein-truncating variant, c.2605A>T (p.Lys869Ter), in the Sphase cyclin A-associated protein in the endoplasmic reticulum (SCAPER) gene. SCAPER has previously been reported to cause IDDRP. In silico analyses revealed structural and interactional alterations in the SCAPER protein. This variant is novel in the Pakistani population and has not been previously reported. This variant exhibits an autosomal recessive mode of inheritance and segregates among the investigated affected and unaffected family members.

conclusionThe present study expands the spectrum of disease-causing variants in SCAPER and will contribute to a better understanding of the genetic etiology of IDDRP.

Indexed as

Intellectual DisabilityMembrane ProteinsRetinitis PigmentosaChildExome SequencingFemaleHumansIntercellular Signaling Peptides and ProteinsMaleMutationPedigreeIntercellular Signaling Peptides and ProteinsMembrane ProteinsTRAPPC9 protein, humanintellectual developmental disorder and retinitis pigmentosaintellectual disabilityprotein modelling and dockingretinitis pigmentosaSCAPERwhole exome sequencing

Identifiers

PMID40143690
PMCPMC13688415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.